12:00 AM
 | 
Oct 11, 1999
 |  BC Week In Review  |  Company News  |  Deals

Axcan, Schwarz Pharma Inc. deal

AXP will purchase for $52 million Schwarz's 50 percent interest in the companies' Axcan Schwarz LLC joint venture, which markets...

Read the full 77 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >